Bayer Cropscience Ltd.
BAYERCROP · NSE · Basic Materials
With a 20% margin of safety, our buy-below price is ₹4,526.6.
Piotroski F-score 4/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%23.7%
- ✓Low debt (D/E < 0.5)0.03x
- ✓Positive free cash flow
- ✕Revenue growth > 10%5%
- ✓Earnings growing13%
- ✓Net margin ≥ 10%12.1%
- ✓Current ratio > 1.51.92
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 6.29
- ✕Piotroski ≥ 74/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Strong return on equity (23.7%).
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 6.29.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Trading in our value buy zone versus sector peers.
- •Trades ~32% below our estimated fair value.
About Bayer Cropscience Ltd.
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that a
More in Chemicals
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.